Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
11/2009
11/04/2009EP1159421B1 Human suppressor of fused
11/04/2009EP1032660B1 Method of identifying binding site domains that retain the capacity of binding to an epitop
11/04/2009EP1004299B1 Vaccine precursors, vaccines for treating tumors
11/03/2009US7612192 Neisseria genomic sequences and methods of their use
11/03/2009US7612190 polynucleotides that code for polypeptides having activity for targeting heterogeneous polypeptides to the surfaces of cytoplasmic membranes, useful for analysis of proteind, delivery of cells expressing the polypeptide to a target site in vivo, preparation of an antibodies and vaccines, and gene therapy
11/03/2009US7612183 Antibodies to myelin associated glycoprotein (MAG); neurological diseases/disorders
11/03/2009US7612182 Anti-IL-6 antibodies, compositions, methods and uses
11/03/2009US7612179 Alzheimer's disease, systemic amyloidosis and other amyloid disorders; kits
11/03/2009US7612178 Anti-IGF-1R antibodies and uses thereof
11/03/2009US7612170 Co-stimulatory polypeptides
11/03/2009US7612168 Modified HIV peptides, antigens, compositions, immunoassay kit and a method of detecting antibodies induced by HIV
11/03/2009US7612044 biodrug contains an immunogenic peptide; encoded from an isolated host cell transfected with the recombinant expression vector; diagnosis of skin cancer; vaccine for prevention and treatment; immunotherapy
11/03/2009US7612041 Osteoporosis; transforming growth factors; pyrogen-free
11/03/2009US7611910 Determining whether cerebralspinal fluid sample contains Chlamydia pneumoniae
11/03/2009US7611909 Near infrared chemiluminescent acridinium compounds and uses thereof
11/03/2009US7611904 Serpentine transmembrane epithelial antigens of the prostate; polynucleotides, recombinant expression vectors, and host cells; anticarcinogenic agents; diagnosis and prognosis of urogenital and bone cancers and lymphomas
11/03/2009US7611894 Anti-idiotype antibodies of the human monoclonal antibody SC-1, and their production and use
11/03/2009US7611855 Permits accurate assay of a target substance in a specimen by the use of two types of characteristic antibodies
11/03/2009US7611846 Diagnostic methods involving human growth factor huXAG-1
11/03/2009US7611709 Contains one antibody and lactosucrose, glucosyl sucrose or maltosyl sucrose; powders made through spray drying or freeze drying
11/03/2009US7611708 Methods of therapy for B-cell malignancies using antagonist anti-CD40 antibodies
11/03/2009US7611707 Glycoprotein VI antibodies and methods thereof
11/03/2009US7611706 RG1 antibodies and uses thereof
11/03/2009US7611704 Compositions and methods for treating viral infections using antibodies and immunoconjugates to aminophospholipids
11/03/2009US7611702 TNF-alpha blocker treatment for enterocolitis associated with immunostimulatory therapeutic antibody therapy
11/03/2009CA2418961C Anti-il-12 antibodies, compositions, methods and uses
11/03/2009CA2385477C Pca3 messenger rna species in benign and malignant prostate tissues
11/03/2009CA2342767C Multihued labels
11/03/2009CA2118243C Methods and compositions for monitoring cellular processing of .beta.-amyloid precursor protein
11/03/2009CA2105618C Humanized antibodies to ganglioside gm2
10/2009
10/29/2009WO2009132251A2 Methods and compositions comprising anti-idiotypic antibodies to anti-mmp-14 antibodies
10/29/2009WO2009132037A1 ANTI-TNFα ANTIBODY
10/29/2009WO2009131702A2 Antibodies against fcrn and use thereof
10/29/2009WO2009131256A1 Humanized antibodies specific for amino acid sequence rgd of an extracellular matrix protein and the uses thereof
10/29/2009WO2009131239A1 Stable polyvalent antibody
10/29/2009WO2009131203A1 Nucleic acid containing chimeric gene derived from hepatitis type-c virus
10/29/2009WO2009130612A2 Prion epitopes and methods of use thereof
10/29/2009WO2009130575A2 Isolated monoclonal antibody or fragment thereof binding prostate specific membrane antigen, conjugates and uses thereof
10/29/2009WO2009130296A2 Anti-alk1 antibodies and uses thereof
10/29/2009WO2009129980A1 Method for the prevention and treatment of cancer by inhibition of gpvi
10/29/2009WO2009129814A1 Methods for manufacturing a polyclonal protein
10/29/2009WO2009129616A1 Genetically modified human umbilical cord perivascular cells for prophylaxis against or treatment of biological or chemical agents
10/29/2009WO2009109911A8 Methods of treating chronic pain
10/29/2009WO2009099719A3 Compositions and methods for the treatment of tumor of hematopoietic origin
10/29/2009WO2009099561A3 Urinary ca125 peptides as biomarkers of ovarian cancer
10/29/2009WO2009082624A3 Antagonists of il-17a, il-17f, and il-23 and methods of using the same
10/29/2009WO2009070243A3 Wise binding antibodies and epitopes
10/29/2009WO2009048538A3 Use of anti-amyloid beta antibody in ocular diseases
10/29/2009US20090271880 Binding molecules
10/29/2009US20090270597 Fibronectin type III (Fn3) for use as diagnostic and treatment tools in gene therapy; identifying the amino acid sequence of a polypeptide molecule capable of binding to a specific binding partner (SBP) so as to form a polypeptide:SSP complex
10/29/2009US20090270596 Chromatography purification of antibodies
10/29/2009US20090270595 Il-1 related polypeptides
10/29/2009US20090270592 Purified TNFR preparations
10/29/2009US20090270591 Novel surface antigen
10/29/2009US20090270506 Crystalline structure of oxidosqualene synthase
10/29/2009US20090270479 Genetic and Epigenetic Alterations In the Diagnosis and Treatment of Cancer
10/29/2009US20090270333 Methods of using motilin homologs
10/29/2009US20090270327 Lepidopteran-Active Bacillus Thuringiensis Delta-Endotoxin Compositions and Methods of Use
10/29/2009US20090270317 Pharmaceutical compositions comprising bioelastomer fusion proteins
10/29/2009US20090270268 Methods for Obtaining Immortalized Antibody Secreting Cells
10/29/2009US20090269850 containing a reduced amount of receptor-binding protein compared with the wild type; modified HVJ containing a reduced amount of HN protein
10/29/2009US20090269844 Nucleic acids encoding a receptor for il-17 homologous polypeptides
10/29/2009US20090269843 Hemopexin fusion proteins
10/29/2009US20090269840 Kinase insert domain-containing receptor (KDR) specific immunoglobulin for monitoring tumor angiogenesis
10/29/2009US20090269811 Il-1 related polypeptides
10/29/2009US20090269789 Antibodies for detecting microorganisms
10/29/2009US20090269787 Monoclonal Antibody to CD166 and Method for Production Thereof
10/29/2009US20090269783 B7-H2 molecules, novel members of the B7 family and uses thereof
10/29/2009US20090269739 Kit for detection of telomerase reverse transcriptase nucleic acids
10/29/2009US20090269371 Process for the production of monoclonal antibodies
10/29/2009US20090269370 Vaccines comprising multimeric hsp60 peptide carriers
10/29/2009US20090269368 Pseudomonas exotoxin a-like chimeric immunogens
10/29/2009US20090269358 Proteins with Improved Solubility and Methods for Producing and Using Same
10/29/2009US20090269357 ANTI-TNFalpha ANTIBODY
10/29/2009US20090269355 Catalytic antibodies and a method of producing same
10/29/2009US20090269350 drug screening; used to identify compounds that act as agonists and antagonists and modulate the expression of the novel PGP synthase
10/29/2009US20090269349 Antigenic polypeptides
10/29/2009US20090269348 Pancreatic Cancer Genes
10/29/2009US20090269347 Pancreatic Cancer Genes
10/29/2009US20090269346 Compositions Comprising Receptor-Associated Protein (RAP) Variants Specific for LRP2 and Uses Thereof
10/29/2009US20090269345 CLN248 Antibody Compositions and Methods of Use
10/29/2009US20090269343 Dual Specific Immunotoxin for Brain Tumor Therapy
10/29/2009US20090269342 Hemagglutinin Polypeptides, and Reagents and Methods Relating Thereto
10/29/2009US20090269341 Lytic domain fusion constructs and methods of making and using same
10/29/2009US20090269338 Humanized anti-factor d antibodies and uses thereof
10/29/2009US20090269336 have a high binding affinity to all five isoforms of human vascular endothelial growth factor (VEGF); for cancer, age-related macular degeneration (AMD), rheumatoid arthritis, and diabetic retinopathy
10/29/2009US20090269333 Replikin peptides in rapid replication of glioma cells and in influenza epidemics
10/29/2009US20090269332 Human diacylglycerol acyltransferase 2 (DGAT2) family members and uses therefor
10/29/2009US20090269304 Methods of treating cancer using il-21 and monoclonal antibody therapy
10/29/2009US20090269302 Human antibodies that bind human il-12 and methods for producing
10/29/2009CA2722348A1 Methods for manufacturing a polyclonal protein
10/29/2009CA2722082A1 Fc receptor binding proteins
10/29/2009CA2722043A1 Nucleic acid comprising chimeric gene derived from hepatitis c virus
10/29/2009CA2722018A1 Method for the prevention and treatment of cancer by inhibition of gpvi
10/29/2009CA2721983A1 Anti-tnf (alpha) antibody
10/29/2009CA2721870A1 Genetically modified human umbilical cord perivascular cells for prophylaxis against or treatment of biological or chemical agents
10/29/2009CA2721833A1 Prion epitopes and methods of use thereof
10/29/2009CA2721716A1 Humanized antibodies specific for amino acid sequence rgd of an extracellular matrix protein and the uses thereof
10/28/2009EP2112231A2 MarA family helix-turn-helix domains and methods of use
10/28/2009EP2112222A1 Gene encoding guanine nucleotide exchange factor and gene product thereof
1 ... 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 ... 1494